No statistically significant differences were observed between the two groups in terms of sex distribution, BMI, presence of comorbidities (DM or hypertension), baseline prolactin levels, other hormonal parameters (LH, E2, and testosterone), adenoma size, cavernous sinus invasion, optic chiasm compression, or initial treatment modalities. The gene discussed is PLOD1; the disease is hypertensive disorder.